|Articles|March 22, 2023
Using Clinical Trial Sites' Input to Select the Right Capabilities when Decentralizing Clinical Trials
Author(s)ZS Associates
This paper analyses the responses from more than 800 US-based clinical trial sites to understand their decentralized clinical trial capabilities and perceptions
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: CRO Partnership in Program Recruitment, Psychedelic Trial Design Guidance, and Breast Cancer Pathway Inhibitor
2
Study Quantifies Financial Return of Risk-Based Quality Management in Oncology Trials
3
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
4
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
5